mannose has been researched along with mart-1 antigen in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dobroff, AS; Moraes, JZ; Rodrigues, EG; Travassos, LR | 1 |
Florindo, HF; Gaspar, M; Graca, L; Oliveira, VG; Préat, V; Salgado, A; Silva, JM; Vandermeulen, G; Videira, M; Zupancic, E | 1 |
2 other study(ies) available for mannose and mart-1 antigen
Article | Year |
---|---|
Protective, anti-tumor monoclonal antibody recognizes a conformational epitope similar to melibiose at the surface of invasive murine melanoma cells.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Antigens, Neoplasm; Cancer Vaccines; Carbohydrate Metabolism; Carbohydrates; Cell Separation; Complement System Proteins; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Epitopes; Flow Cytometry; Galactose; Glutaral; Humans; Hybridomas; Immunoglobulin G; Immunotherapy; Lactose; Mannose; MART-1 Antigen; Melanoma; Melanoma, Experimental; Melibiose; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Fluorescence; Mucins; N-Acetylneuraminic Acid; Neoplasm Proteins; Protein Conformation; Trypanosoma cruzi | 2002 |
In vivo delivery of peptides and Toll-like receptor ligands by mannose-functionalized polymeric nanoparticles induces prophylactic and therapeutic anti-tumor immune responses in a melanoma model.
Topics: Animals; Cancer Vaccines; Cell Line, Tumor; Cytokines; Disease Models, Animal; Female; gp100 Melanoma Antigen; Granzymes; Immunoglobulin G; Ligands; Male; Mannose; MART-1 Antigen; Melanoma; Mice, Inbred C57BL; Mice, Transgenic; Nanoparticles; Oligodeoxyribonucleotides; Ovalbumin; Peptides; Poly I-C; Polymers; Toll-Like Receptors; Tumor Burden | 2015 |